Last deal
Amount
Stage
Date
all rounds
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Contacts
Similar Companies1000
Thrasos
Thrasos develops targeted therapies for severe organ failures.
Sector
Subsector
Location
total rounds
total raised
Visgo Therapeutics
Visgo Therapeutics develops innovative solutions for joint diseases, focusing on localized treatment with minimal systemic impact.
Sector
Subsector
Location
total rounds
total raised
Prosalix
Prosalix is a company that develops therapeutics to treat acid-base imbalances.
Sector
Subsector
Keywords
Location
Oxalo Therapeutics
Oxalo Therapeutics develops a drug to prevent recurrent kidney stones.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds1
Number of Funding Rounds
Their latest funding was raised on 01.01.2020. Their latest investor Accelerate New York Seed Fund. Their latest round Seed
Co-Investors
Investors1
Number of lead investors
Number of investors
Accelerate New York Seed Fund
Accelerate NY Seed Fund provides funding for science and technology-based early stage ventures.
Sector
Subsector
Keywords
Location
count Of Investments
People
Founders3
Arthur Klausner
Arthur Klausner is a co-founder, CEO, and President at Goldilocks Therapeutics.
current job
organization founded
Arthur Klausner
Daniel A. Heller
Daniel A. Heller is the Co-Founder and Chief Scientific Officer at Goldilocks Therapeutics.
current job
organization founded
Daniel A. Heller
Edgar A. Jaimes
Edgar A. Jaimes is the Co-Founder and Chief Medical Officer at Goldilocks Therapeutics.
current job
organization founded
Edgar A. Jaimes
Employee Profiles3
Edgar A. Jaimes
Co-Founder and Chief Medical Officer
Daniel A. Heller
Co-Founder and Chief Scientific Officer